Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children
Oded Gilad,
Orly Dgany,
Sharon Noy-Lotan,
Tanya Krasnov,
Joanne Yacobovich,
Ron Rabinowicz,
Tracie Goldberg,
Amir A. Kuperman,
Abed Abu-Quider,
Hagit Miskin,
Noa Kapelushnik,
Noa Mandel-Shorer,
Shai Shimony,
Dan Harlev,
Tal Ben-Ami,
Etai Adam,
Carina Levin,
Shraga Aviner,
Ronit Elhasid,
Sivan Berger-Achituv,
Lilach Chaitman-Yerushalmi,
Yona Kodman,
Nino Oniashvilli,
Michal Hameiri-Grosman,
Shai Izraeli,
Hannah Tamary,
Orna Steinberg-Shemer
Affiliations
Oded Gilad
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv
Orly Dgany
Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva
Sharon Noy-Lotan
Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva
Tanya Krasnov
Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva
Joanne Yacobovich
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv
Ron Rabinowicz
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv
Tracie Goldberg
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv
Amir A. Kuperman
Blood Coagulation Service and Pediatric Hematology Clinic, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed
Abed Abu-Quider
Pediatric Hematology, Soroka University Medical Center, Ben-Gurion University, Beer Sheva
Hagit Miskin
Pediatric Hematology Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem
Noa Kapelushnik
Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Goldschleger Eye Institute, Sheba Medical Center, Hashomer
Noa Mandel-Shorer
Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Healthcare Campus; Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa
Shai Shimony
Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Rabin Medical Center, Institute of Hematology, Davidoff Cancer Centre, Beilinson Hospital, Petach-Tikva, Israel; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dan Harlev
Pediatric Hematology-Oncology Department, Hadassah University Medical Center, Jerusalem
Tal Ben-Ami
Pediatric Hematology Unit, Kaplan Medical Center, Rehovot, Israel; Faculty of Medicine, Hebrew University of Jerusalem
Etai Adam
Pediatric Hematology-Oncology Department, Sheba Medical Center, Hashomer
Carina Levin
Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa, Israel; Pediatric Hematology Unit and Research Laboratory, Emek Medical Center, Afula
Shraga Aviner
Department of Pediatrics, Barzilai University Medical Center, Ashkelon, affiliated to Ben Gurion University, Beer-Sheva
Ronit Elhasid
Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Department of Pediatric Hemato-Oncology, Aviv Medical Center
Sivan Berger-Achituv
Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Department of Pediatric Hemato-Oncology, Aviv Medical Center
Lilach Chaitman-Yerushalmi
Genoox, Health Care Technology, Aviv
Yona Kodman
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva
Nino Oniashvilli
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva
Michal Hameiri-Grosman
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva
Shai Izraeli
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv
Hannah Tamary
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva
Orna Steinberg-Shemer
Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Aviv University, Aviv, Israel; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva
Prolonged cytopenias are a non-specific sign with a wide differential diagnosis. Among inherited disorders, cytopenias predisposing to leukemia require a timely and accurate diagnosis to ensure appropriate medical management, including adequate monitoring and stem cell transplantation prior to the development of leukemia. We aimed to define the types and prevalences of the genetic causes leading to persistent cytopenias in children. The study comprises children with persistent cytopenias, myelodysplastic syndrome, aplastic anemia, or suspected inherited bone marrow failure syndromes, who were referred for genetic evaluation from all pediatric hematology centers in Israel during 2016-2019. For variant detection, we used Sanger sequencing of commonly mutated genes and a custom-made targeted next-generation sequencing panel covering 226 genes known to be mutated in inherited cytopenias; the minority subsequently underwent whole exome sequencing. In total, 189 children with persistent cytopenias underwent a genetic evaluation. Pathogenic and likely pathogenic variants were identified in 59 patients (31.2%), including 47 with leukemia predisposing syndromes. Most of the latter (32, 68.1%) had inherited bone marrow failure syndromes, nine (19.1%) had inherited thrombocytopenia predisposing to leukemia, and three each (6.4%) had predisposition to myelodysplastic syndrome or congenital neutropenia. Twelve patients had cytopenias with no known leukemia predisposition, including nine children with inherited thrombocytopenia and three with congenital neutropenia. In summary, almost one third of 189 children referred with persistent cytopenias had an underlying inherited disorder; 79.7% of whom had a germline predisposition to leukemia. Precise diagnosis of children with cytopenias should direct follow-up and management programs and may positively impact disease outcome.